SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery

The transcription factor SOX2 is a well-established and important stem cell marker. Its role in cancer biology remains unclear, but it has been proposed to also be a marker of cancer stem cells. We investigated the role of SOX2 protein expression in women with high-grade serous ovarian cancer (HGSOC...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Cell Oncol
Päätekijät: Bååth, Maria, Westbom-Fremer, Sofia, Martin de la Fuente, Laura, Ebbesson, Anna, Davis, Juliette, Malander, Susanne, Måsbäck, Anna, Kannisto, Päivi, Hedenfalk, Ingrid
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Taylor & Francis 2020
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7671002/
https://ncbi.nlm.nih.gov/pubmed/33235906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2020.1805094
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia